Breast Proliferative Changes

Breast proliferative changes represent a group of benign breast conditions where cells in the breast ducts or lobules grow faster than normal. While most of these changes are not cancerous, some types can increase a woman’s risk of developing breast cancer in the future.

Table of contents

• What Are Breast Proliferative Changes?
• Types of Proliferative Breast Changes
• Associated Anatomy
• What Causes These Changes?
• Signs and Symptoms
• Breast Cancer Risk
• How Are They Diagnosed?
• Treatment and Management
• Lifestyle and Prevention

What Are Breast Proliferative Changes?

Breast proliferative changes are benign (not cancerous) breast conditions where cells in the breast grow faster than normal. The term “proliferative” means that cells are multiplying or dividing more rapidly than usual^[1]. These changes happen in the main structures of the breast, including the stroma (connective tissue), ducts (tubes that carry milk), and lobules (milk-producing glands)^[1].

While these changes are not cancer, they are important to recognize because some types can increase a woman’s risk of developing breast cancer later in life^[1]. The level of risk depends on whether the proliferating cells look normal or abnormal under a microscope.

Types of Proliferative Breast Changes

Breast proliferative changes are divided into different categories based on how the cells look under a microscope. The main distinction is whether the cells appear normal or show abnormal features called atypia^[4].

Proliferative Lesions Without Atypia

In these conditions, cells are growing faster than normal but still look normal under a microscope. These conditions include^[4]:

• Ductal hyperplasia (without atypia) – increased cell growth in the milk ducts
• Complex fibroadenoma – a benign breast lump with some complex features
• Sclerosing adenosis – enlarged lobules with scar-like tissue
• Papilloma or papillomatosis – small, finger-like growths in the ducts
• Radial scar – a star-shaped area of tissue that can look suspicious on imaging

Having one of these conditions can double a woman’s breast cancer risk compared to women without proliferative breast conditions^[4].

Proliferative Lesions With Atypia

These conditions involve cells that are growing faster than normal and also look abnormal under the microscope. The two main types are^[4]:

• Atypical ductal hyperplasia – abnormal cell growth in the ducts
• Atypical lobular hyperplasia – abnormal cell growth in the lobules

Being diagnosed with one of these conditions can make breast cancer risk 4 to 5 times higher than normal. If a woman with atypical hyperplasia also has a strong family history of breast cancer, her risk can be even higher^[4].

Lobular Carcinoma in Situ (LCIS)

Although its name includes the word “carcinoma,” lobular carcinoma in situ is not actually a true breast cancer. It describes abnormal cell growth in the breast lobules. Women diagnosed with LCIS have a breast cancer risk that is 7 to 11 times higher than average. This risk becomes even higher when combined with a strong family history^[4].

• Breast ducts
• Breast lobules
• Breast stroma (connective tissue)

What Causes These Changes?

The exact cause of breast proliferative changes is not completely understood. However, research has identified several important factors that play a role^[1].

Hormonal Factors

Hormones appear to be a major factor in breast proliferative changes. During a woman’s reproductive years, breast tissue responds directly to cyclical changes in the hormones estradiol and progesterone^[1]. The breast tissue may undergo fibrocystic changes during these hormonal fluctuations, which are normal changes that affect up to 50% of women clinically and up to 90% of women when examined under a microscope^[2].

Studies show a strong connection between estrogen exposure and benign breast disease. Women taking estrogen and progestin together for over eight years have a 1.7-fold increased prevalence of benign breast lesions. The Women’s Health Initiative study found that the combined use of estrogen and progestin correlated with a 74% risk of benign breast disease. Conversely, the use of anti-estrogens led to a 28% reduction in proliferative breast disease^[1].

Other Contributing Factors

Additional factors that may contribute to proliferative breast changes include^[5]:

• Age – particularly during the 30s and 40s
• Body Mass Index (BMI)
• Family history of breast cancer or benign breast conditions
• Genetic tendencies

Signs and Symptoms

Many women with proliferative breast changes do not experience any symptoms. When symptoms do occur, they may include^[2]:

• Breast lumps or areas of thickening that blend into surrounding breast tissue
• Generalized breast pain or tenderness
• Discomfort in the upper outer part of the breast
• Breast lumps or lumpy tissue that changes in size with the menstrual cycle
• Green or dark brown nipple discharge that is not bloody

For women with fibrocystic changes (a common type of proliferative change), symptoms often follow a pattern. Breast pain, tenderness, and lumpiness tend to be most bothersome just before menstruation and improve after the period starts^[2].

It’s important to remember that a palpable mass can occur in both benign and malignant breast conditions. Clinical findings that require medical evaluation include skin dimpling, thickening, pain, and nipple discharge^[1].

Breast Cancer Risk

Understanding the cancer risk associated with different types of proliferative breast changes is important for making informed decisions about monitoring and treatment.

Nonproliferative Lesions

Nonproliferative breast lesions are generally not associated with an increased risk of breast cancer^[1]. Simple cysts and fibroadenomas fall into this category and typically require no treatment.

Proliferative Lesions Without Atypia

These conditions slightly increase breast cancer risk. Women with usual hyperplasia (the most common form) have about twice the breast cancer risk of women without a proliferative breast condition^[7].

Proliferative Lesions With Atypia

Atypical hyperplasia significantly increases breast cancer risk. Women with atypical hyperplasia have about 3 to 5 times the breast cancer risk of women without a proliferative breast condition. The risk is even higher when combined with a family history of breast cancer^[7].

Important Context

Benign breast disease associates with up to a 50% risk of developing breast cancer under certain histopathological and clinical circumstances^[1]. However, it’s crucial to remember that 70 to 80% of breast cancer patients have no family history. This means that for most women, lifestyle choices are likely much more important than genetics in preventing breast cancer^[5].

How Are They Diagnosed?

Diagnosing proliferative breast changes typically involves a combination of clinical examination, imaging, and tissue analysis.

Clinical Examination

A healthcare provider examines the breasts and checks the lymph nodes in the lower neck and underarm area for unusual breast tissue. If the breast exam along with your medical history suggests normal breast changes, you may not need additional tests^[10].

Imaging Studies

The most common tools to assess clinical findings are mammograms and ultrasound^[1]. A mammogram is an X-ray examination that can detect abnormalities in breast tissue. Ultrasound uses sound waves to produce images of the breasts and is particularly useful for evaluating dense breast tissue in younger women^[10].

Biopsy

If imaging tests or clinical examination reveal concerning findings, a biopsy is performed. During a biopsy, a sample of breast tissue is removed and examined by a pathologist under a microscope. Atypical hyperplasia is most often diagnosed during a breast biopsy^[13].

The pathologist evaluates the cellular and architectural characteristics of the breast tissue. If atypia is seen, they will assess the degree of atypia and identify the specific type, such as atypical ductal hyperplasia or atypical lobular hyperplasia^[23].

Treatment and Management

Treatment for proliferative breast changes depends on the type of change, the presence of symptoms, and the level of cancer risk.

When Treatment Is Not Needed

If breast changes are determined to be benign and do not cause symptoms, then no treatment is necessary^[1]. Many nonproliferative lesions, such as simple cysts and fibroadenomas, often go away without treatment^[8].

Surgery

For atypical hyperplasia, surgery may be recommended to remove the atypical cells. However, not everyone needs surgery. Healthcare providers typically decide whether to recommend surgery based on mammogram images, biopsy results, and other factors such as medical history^[13].

During surgery, the removed tissue is tested in the lab to look for signs of cancer. Most people who have surgery for atypical hyperplasia do not have breast cancer, but sometimes the surgery finds noninvasive breast cancer (ductal carcinoma in situ) or invasive breast cancer^[13].

Enhanced Screening

For women with atypical hyperplasia who also have a 20% or greater lifetime risk of invasive breast cancer, special breast cancer screening recommendations apply. The National Comprehensive Cancer Network recommends^[7]:

• Clinical breast exam and risk assessment every 6-12 months, starting by age 25
• Annual mammogram with digital breast tomosynthesis, starting at age 30
• Discussion with a healthcare provider about annual breast MRI screening, starting at age 25

Screening helps ensure that if breast cancer does develop, it’s caught early when the chances of survival are highest^[7].

Risk-Reduction Medications

For women at high risk, certain hormonal therapy medicines have been shown to reduce the risk of developing hormone-receptor-positive breast cancer. These include^[4]:

• Tamoxifen – shown to reduce risk in both postmenopausal and premenopausal women at high risk
• Raloxifene (Evista) – shown to reduce risk in postmenopausal women
• Exemestane (Aromasin) – an aromatase inhibitor that reduces risk in postmenopausal women at high risk

Lifestyle and Prevention

There are several lifestyle changes women can make to help ease symptoms caused by fibrocystic and other proliferative breast changes and potentially reduce their occurrence.

Self-Care Measures

Simple self-care measures can usually relieve discomfort associated with proliferative breast changes. These include^[1]:

• Taking over-the-counter pain relievers such as acetaminophen or ibuprofen
• Applying heat or ice to the breast
• Wearing a well-fitting supportive bra, such as a sports bra

Weight Management

Maintaining a healthy weight is one of the most important ways to reduce breast cancer risk. Research shows that maintaining a healthy weight throughout life helps protect against common cancers, including breast cancer^[24].

Physical Activity

Regular exercise can help lower the chances of developing breast cancer. Physical activity also helps maintain a healthy weight, which provides additional protection^[20].

Dietary Choices

While some women believe that eating less fat, caffeine, or chocolate helps with symptoms, there is no clear evidence that these measures help large numbers of women^[17]. However, some studies suggest that a diet high in fruits, vegetables, and calcium-rich dairy products, and low in red and processed meats, might help lower the risk of breast cancer^[6].

Limiting Alcohol

The more alcohol you drink, the greater your risk of developing breast cancer. It’s safest not to drink alcohol, but if you do, limit consumption to no more than one drink per day. Even small amounts raise the risk of breast cancer^[20].

Avoiding Tobacco

There is evidence that smoking may increase breast cancer risk. Women who never smoke or who quit smoking reduce their breast cancer risk^[4].

Regular Self-Awareness

While routine breast self-exams have not been shown to decrease the chance of dying from breast cancer, becoming familiar with how your breasts normally feel can make it easier to notice any changes. Always check with your doctor or nurse about breast changes^[25].